The AUC for TEMs was 0.692 in differentiating AFP-negative HCC from LC patients (95% CI 0.564–0.819), with a sensitivity of 80.0% and a specificity of 65.52%. This evidence concerns the gene AFP and hepatocellular carcinoma.